Market cap
$106 Mln
Revenue (TTM)
$20 Mln
P/E Ratio
--
P/B Ratio
3.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
-3.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
27,470,900
10 Years Aggregate
CFO
$-56.63 Mln
EBITDA
$-77.69 Mln
Net Profit
$-130.33 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
icad inc (ICAD)
| 111.5 | 1.0 | 26.1 | 182.5 | -3.0 | -17.9 | 0.3 |
|
BSE Sensex*
| -10.8 | -0.6 | -1.7 | -8.5 | 6.4 | 7.6 | 11.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
icad inc (ICAD)
| 3.4 | -3.3 | -74.6 | -45.5 | 69.9 | 110.0 | 7.5 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
icad inc (ICAD)
|
3.9 | 106.3 | 19.5 | -5.2 | -27.7 | -17.4 | -- | 3.5 |
| 1.3 | 64.4 | 80.0 | -47.5 | -37.3 | -- | -- | 6.5 |
Shareholding Pattern
View DetailsAbout icad inc (ICAD)
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and... cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Detection solutions include advanced artificial intelligence and image analysis workflow solutions to identifying pathologies and pinpointing prevalent cancers earlier; and a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging, and computed tomography. In addition, the company suite offers solutions for cancer detection, density assessment, and personalized risk evaluation based on a 2D or 3D mammogram's collection of images. Additionally, its density assessment standardizes and simplifies breast density reporting by algorithmically examining a woman's breast anatomy from the mammogram image. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Read more
-
President, CEO & Executive Chair
Ms. Dana R. Brown
-
President, CEO & Executive Chair
Ms. Dana R. Brown
-
Headquarters
Nashua, NH
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for icad inc (ICAD)
What is the current share price of icad inc (ICAD) Today?
The share price of icad inc (ICAD) is $3.87 (NASDAQ) as of 17-Jul-2025 09:30 EDT. icad inc (ICAD) has given a return of -3% in the last 3 years.
What is the current PB & PE ratio of icad inc (ICAD)?
Since, TTM earnings of icad inc (ICAD) is negative, P/E ratio is not available.
The P/B ratio of icad inc (ICAD) is 3.45 times as on 17-Jul-2025, a 2 premium to its peers’ median range of 3.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-8.59
|
1.68
|
|
2023
|
-9.61
|
1.39
|
|
2022
|
-3.39
|
1.32
|
|
2021
|
-16.09
|
3.89
|
|
2020
|
-17.29
|
9.98
|
What is the 52 Week High and Low of icad inc (ICAD)?
The 52-week high and low of icad inc (ICAD) are Rs 4.02 and Rs 1.19 as of 13-Jun-2026.
What is the market cap of icad inc (ICAD)?
icad inc (ICAD) has a market capitalisation of $ 106 Mln as on 17-Jul-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in icad inc (ICAD)?
Before investing in icad inc (ICAD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.